- Work address
-
Secretariaat Voorzitter Inwendige Ziekten C. Heymanslaan 10
9000 Gent - Justine.Defreyne@UGent.be
- ORCID iD
-
0000-0002-6570-2340
Show
Sort by
-
- Journal Article
- A1
- open access
Change in visceral fat and total body fat and the effect on cardiometabolic risk factors during transgender hormone therapy
-
Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
-
Characterisation of testicular function and spermatogenesis in transgender women
-
Low feasibility of in vitro matured oocytes originating from cumulus complexes found during ovarian tissue preparation at the moment of gender confirmation surgery and during testosterone treatment for fertility preservation in transgender men
-
Sexual orientation in transgender individuals : results from the longitudinal ENIGI study
-
- Journal Article
- A1
- open access
Positive and negative affect changes during gender-affirming hormonal treatment : results from the European Network for the Investigation of Gender Incongruence (ENIGI)
-
- Journal Article
- A1
- open access
Lower serum estradiol levels in assigned female at birth transgender people with initiation of testosterone therapy : results from the European Network for the Investigation of Gender Incongruence
-
Organizing the voice questionnaire for transgender persons
-
Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy : a prospective cohort study (ENIGI)
-
Gender affirming endocrine care in adults
(2020)